- Home
- TKNO vs INO Comparison
TKNO vs INO Comparison
Compare TKNO & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TKNO | INO |
|---|---|---|
| Founded | 1996 | 1979 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.1M | 116.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TKNO | INO |
|---|---|---|
| Price | $2.01 | $1.65 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 371.9K | ★ 1.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.64 | N/A |
| Revenue Next Year | $9.73 | $23,060.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.91 | $1.30 |
| 52 Week High | $8.65 | $2.98 |
Technical Indicators
Market Signals| Indicator | TKNO | INO |
|---|---|---|
| Relative Strength Index (RSI) | 16.20 | 49.02 |
| Support Level | $1.96 | $1.56 |
| Resistance Level | $2.26 | $1.78 |
| Average True Range (ATR) | 0.28 | 0.12 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 6.59 | 55.17 |
Price Performance
Historical ComparisonAbout TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.